Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Loriot

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2011
Internet to boost patient accrual in oncology trials? A multiinstitutional AERIO studyM J Rodrigues, S Haberer, D Dionysopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?C Massard, A Plantade, M Gross-Goupil, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2010
Prevalence and causes of burnout amongst oncology residents: a comprehensive nationwide cross-sectional studyP Blanchard, D Truchot, L Albiges-Sauvin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)Y Loriot, D Bianchini, E Ileana, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 30, 2009
KIT expression in postradiation sarcomaF Andreiuolo, J Calderaro, Y Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancerS Rajpar, C Massard, A Laplanche, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC)Y Neuzillet, F Audenet, Y Loriot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)Y Neuzillet, B Pradère, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC)Y Neuzillet, T Seisen, O Traxer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 13, 2022
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer]P Leon, F Saint, F Audenet, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2011
Internet to boost patient accrual in oncology trials? A multiinstitutional AERIO studyM J Rodrigues, S Haberer, D Dionysopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?C Massard, A Plantade, M Gross-Goupil, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2010
Prevalence and causes of burnout amongst oncology residents: a comprehensive nationwide cross-sectional studyP Blanchard, D Truchot, L Albiges-Sauvin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)Y Loriot, D Bianchini, E Ileana, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 30, 2009
KIT expression in postradiation sarcomaF Andreiuolo, J Calderaro, Y Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancerS Rajpar, C Massard, A Laplanche, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC)Y Neuzillet, F Audenet, Y Loriot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)Y Neuzillet, B Pradère, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC)Y Neuzillet, T Seisen, O Traxer, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 13, 2022
[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer]P Leon, F Saint, F Audenet, et al.
Pageof 8